Transforming growth factor β1 induces differentiation in human papillomavirus-positive keratinocytes

Journal of Virology

Volumn 70, Issue 8, 1996, Pages 5437-5446

  Ozbun, Michelle A ^a   Meyers, Craig ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL DIFFERENTIATION; CYTOARCHITECTURE; GROWTH REGULATION; HUMAN; HUMAN CELL; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; VIRUS EXPRESSION; WART VIRUS;

EID: 0029896845     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.8.5437-5446.1996     Document Type: Article

References (59)

1. Akhurst, R. J., F. Fee, and A. Balmain. 1988. Localized production of TGF-β mRNA in tumour promoter-stimulated mouse epidermis. Nature (London) 331:363-365.
2. Baird, A., and T. Durkin. 1986. Inhibition of endothelial cell proliferation by type β-transforming growth factor: interactions with acidic and basic fibroblast growth factors. Biochem. Biophys. Res. Commun. 138:476-482.
3. Bedell, M. A., J. B. Hudson, T. R. Golub, M. E. Turyk, M. Hosken, G. D. Wilbanks, and L. A. Laimins. 1991. Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation. J. Virol. 65:2254-2260.
4. Blanton, R. A., N. Perez-Reyes, D. T. Merrick, and J. K. McDougall. 1991. Epithelial cells immortalized by human papillomaviruses have premalignant characteristics in organotypic culture. Am. J. Pathol. 138:673-685.
5. Boukamp, P., R. T. Pelrussevdka, D. Breitkreutz, J. Hornung, A. Markham, and N. E. Fusenig. 1988. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106:761-771.
6. Braun, L., M. Dürst, R. Mikumo, A. Crowley, and M. Robinson. 1992. Regulation of growth and gene expression in human papillomavirus-transformed keratinocytes by transforming growth factor-β: implications for the control of papillomavirus infection. Mol. Carcinog. 6:100-111.
7. 1. Cancer Res. 50: 7324-7332.
8. Cohen, R., M. Pacifici, N. Rubenstein, J. Biehl, and H. Holtzer. 1977. Effect of a tumour promoter on myogenesis. Nature (London) 266:538-540.
9. Cullen, A. P., R. Reid, M. Campion, and A. T. Lörincz. 1991. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J. Virol. 65:606-612.
10. Dagnino, L., J. A. Pietenpol, E. Y. Yang, and H. L. Moses. 1993. Transforming growth factor regulation of keratinocyte growth. Recent Results Cancer Res. 128:15-29.
11. Dale, B. A., K. A. Resing, and J. D. Lonsdale-Eccles. 1985. Filaggrin: a keratin filament associated protein. Ann. N. Y. Acad. Sci. 455:330-342.
12. De Geest, K., C. A. Bergman, M. E. Turyk, B. S. Frank, and G. D. Wilbanks. 1994. Differential response of cervical intraepithelial and cervical carcinoma cell lines to transforming growth factor-β1. Gynecol. Oncol. 55:376-385.
13. De Geest, K., M. E. Turyk, M. I. Hosken, J. B. Hudson, L. A. Laimins, and G. D. Wilbanks. 1993. Growth and differentiation of human papillomavirus type 31b positive human cervical cell lines. Gynecol. Oncol. 49:303-310.
14. Diamond, L., T. G. O'Brien, and G. Rovera. 1977. Inhibition of adipose conversion of 3T3 fibroblasts by tumour promoters, Nature (London) 269: 247-248.
15. DiPaolo, J. A., C. D. Woodworth, N. C. Popescu, V. Notario, and J. Doniger. 1989. Induction of human cervical squamous cell carcinoma by sequential transfection with human papillomavirus 16 DNA and viral Harvey ras. Oncogene 4:395-399.
16. Dürst, M., D. Gallahan, G. Jay, and J. S. Rhim. 1989. Glucocorticoid-enhanced neoplastic transformation of human keratinocytes by human papillomavirus type 16 and an activated ras oncogene. Virology 173:767-771.
17. Eichner, R., P. Bonitz, and T.-T. Sun. 1984. Classification of epidermal keratins according to their immunoreactivity, isoelectric point, and mode of expression. J. Cell. Biol. 98:1388-1396.
18. Fuchs, E. 1993. Epidermal differentiation and keratin gene expression. J. Cell Sci. 17(Suppl.):197-208.
19. Fuchs, E., and H. Green. 1981. Regulation of terminal differentiation of cultured human keratinocytes by vitamin A. Cell 25:617-625.
20. Fusenig, N. E., D. Breitkreutz, P. Boukamp, P. Tomakidi, and H.-J. Stark. 1995. Differentiation and tumor progression. Recent Results Cancer Res. 139:1-19.
21. Hamel, E., F. Katoh, G. Mueller, W. Birchmeier, and H. Yamasaki. 1988. Transforming growth factor β as a potent promoter in two-stage BALB/c 3T3 cell transformation. Cancer Res. 48:2832-2836.
22. Hawley-Nelson, P., K. H. Vousden, N. L. Hubbert, D. R. Lowy, and J. T. Schiller. 1989. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J. 8:3905-3910.
23. Hudson, J. B., M. A. Bedell, D. J. McCance, and L. A. Laimins. 1990. Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18. J. Virol. 64:519-526.
24. Hummel, M., J. B. Hudson, and L. A. Laimins. 1992. Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J. Virol. 66:6070-6080.
25. Ignotz, R, A., and J. Massagué. 1985. Type β transforming growth factor controls the adipogenic differentiation of 3T3 fibroblasts. Proc. Natl. Acad. Sci. USA 82:8530-8534.
26. Jeon, S., B. L. Allen-Hoffmann, and P. F. Lambert. 1995. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J. Virol. 69:2989-2997.
27. Kopan, R., G. Traska, and E. Fuchs. 1987. Retinoids as important regulators of terminal differentiation: examining keratin expression in individual epidermal cells at various stages of keratinization. J. Cell. Biol. 105:427-440.
28. Lorincz, A. T., R. Reid, A. B. Jenson, M. D. Greenburg, W. Lancaster, and R. J. Kurman. 1992. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet. Gynecol. 79:328-337.
29. Massagué, J. 1990. The transforming growth factor-β family. Annu. Rev. Cell Biol. 6:597-641.
30. Massagué, J., S. Cheifetz, T. Endo, and B. Nadal-Ginard. 1986. Type β transforming growth factor is an inhibitor of myogenic differentiation. Proc. Natl. Acad. Sci. USA 83:8206-8210.
31. Masui, T., L. M. Wakefield, J. F. Lechner, M. A. LaVeck, M. B. Sporn, and C. C. Harris. 1986. Type β transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc. Natl. Acad. Sci. USA 83:2438-2442.
32. McCance, D. J., R. Kopan, E. Fuchs, and L. A. Laimins. 1988. Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proc. Natl. Acad. Sci. USA 85:7169-7173.
33. Merrick, D. T., R. A. Blanton, A. M. Gown, and J. K. McDougall. 1992. Altered expression of proliferation and differentiation markers in HPV 16 and 18 immortalized cells grown in organotypic culture. Am. J. Pathol. 140:167-177.
34. Meyers, C. Organotypic (raft) epithelial culture system for the differentiation-dependent replication of papillomavirus. Methods Cell Sc., in press.
35. Meyers, C., M. G. Frattini, J. B. Hudson, and L. A. Laimins. 1992. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 257:971-973.
36. Moll, R., W. W. Franke, D. L. Schiller, B. Geiger, and R. Krepler. 1982. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors, and cultured cells. Cell 31:11-24.
37. Montesano, R., and L. Orci. 1985. Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell 42:469-477.
38. Moses, H. L., E. Y. Yang, and J. A. Pietenpol. 1990. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63:245-247.
39. Münger, K., W. C. Phelps, V. Bubb, P. M. Howley, and R. Schlegel. 1989. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol. 63:4417-4421.
40. Nowell, P. C. 1976. The clonal evolution of tumor cell populations. Science 194:23-28.
41. Pietenpol, J. A., R. W. Stein, E. Moran, P. Yaciuk, R. Schlegel, R. M. Lyons, M. R. Pittlelkow, K. Münger, P. M. Howley, and H. L. Moses. 1990. TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61:777-785.
42. Rader, J. S., T. R. Golub, J. B. Hudson, D. Patel, M. A. Bedell, and L. A. Laimins. 1990. In vitro differentiation of epithelial cells from cervical neoplasias resembles in vivo lesions. Oncogene 5:571-576.
43. Rheinwald, J. G., and M. A. Beckett. 1986. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res. 41:1657-1663.
44. Roberts, A. B., M. B. Sporn, R. K. Assoian, J. M. Smith, N. S. Roche, L. M. Wakefield, U. I. Heine, L. A. Liotta, V. Falanga, J. M. Kehrl, and A. S. Fauci. 1986. Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA 83:4167-4171.
45. Rösl, F., M. Dürst, and H. zur Hausen. 1988. Selective suppression of human papillomavirus transcription in non-tumorigenic cells by 5-azacytidine. EMBO J. 7:1321-1328.
46. Sang, B.-C., and M. S. Barbosa. 1992. Increased E6/E7 transcription in HPV 18-immortalized human keratinocytes results from inactivation of E2 and additional cellular events. Virology 189:448-455.
47. Schneider-Gädicke, A., and E. Schwarz. 1986. Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J. 5:2285-2292.
48. Shipley, G. D., M. R. Pittelkow, J. J. Wille, Jr., R. E. Scott, and H. L. Moses. 1986. Reversible inhibition of normal human prokeratinocyte proliferation by type β transforming growth factor-growth inhibitor in serum-free medium. Cancer Res. 46:2068-2071.
49. Smotkin, D., and F. O. Wettstein. 1986. Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc. Natl. Acad. Sci. USA 83:4680-4684.
50. Sporn, M. B., and A. B. Roberts. 1990. TGF-β: problems and prospects. Cell Reg. 1:875-882.
51. Taichman, L. P., and R. F. LaPorta. 1986. The expression of papillomaviruses in epithelial cells, 109-139. In N. Salamans and P. M. Howley (ed.), The Papovaviridae, vol. 2. The Papillomaviruses. Plenum Press, New York.
52. Tso, J. Y., X. H. Sun, T. H. Kao, K. S. Reece, and R. Wu. 1985. Isolation and characterization of rat and human glyceraldehyde-3-phophate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 13:2485-2502.
53. von Knebel Doeberitz, M., T. Oltersdorf, E. Schwartz, and L. Gissmann. 1988. Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. Cancer Res. 48:3780-3786.
54. Vousden, K. 1993. Interactions of human papillomavirus transforming proteins with the products of tumor suppressor genes. FASEB J. 7:872-879.
55. Waddington, C. H. 1935. Cancer and the theory of organizers. Nature (London) 135:606-608.
56. Willey, J. C., C. E. Moser, Jr., J. F. Lechner, and C. C. Harris. 1984. Differential effects of 12-O-tetradecanoylphorbol-13-acetate on cultured normal and neoplastic human bronchial epithelial cells. Cancer Res. 44: 5124-5126.
57. Woodworth, C. D., V. Notario, and J. A. DiPaolo. 1990. Transforming growth factors beta 1 and 2 transcriptionally regulate human papillomavirus (HPV) type 16 early gene expression in HPV-immortalized human genital epithelial cells. J. Virol. 64:4767-4775.
58. zur Hausen, H. 1986. Intracellular surveillance of persisting viral infections: human genital cancer results from deficient cellular control of papillomavirus gene expression. Lancet ii:489-491.
59. zur Hausen, H. 1991. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184:9-13.